Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Maziarz, Richard T, Levis, Mark, Patnaik, Mrinal M, Scott, Bart L, Mohan, Sanjay R, Deol, Abhinav, Rowley, Scott D, Kim, Dennis D H, Hernandez, Daniela, Rajkhowa, Trivikram, Haines, Kelly, Bonifacio, Gaetano, Rine, Patrice, Purkayastha, Das, Fernandez, Hugo F
Published in Bone marrow transplantation (Basingstoke) (01.05.2021)
Published in Bone marrow transplantation (Basingstoke) (01.05.2021)
Get full text
Journal Article
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
Pratz, Keith W., Sato, Takashi, Murphy, Kathleen M., Stine, Adam, Rajkhowa, Trivikram, Levis, Mark
Published in Blood (18.02.2010)
Published in Blood (18.02.2010)
Get full text
Journal Article
A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
Lee, Lauren, Hizukuri, Yoshiyuki, Severson, Paul, Powell, Benjamin, Zhang, Chao, Ma, Yan, Narahara, Maiko, Sumi, Hiroyuki, Hernandez, Daniela, Rajkhowa, Trivikram, Bollag, Gideon, Levis, Mark
Published in Haematologica (Roma) (01.04.2021)
Published in Haematologica (Roma) (01.04.2021)
Get full text
Journal Article
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Pratz, Keith W, Kaplan, Jason, Levy, Moshe, Bixby, Dale, Burke, Patrick W, Erba, Harry, Wise-Draper, Trisha M, Roboz, Gail J, Papadantonakis, Nikolaos, Rajkhowa, Trivikram, Hernandez, Daniela, Dobler, Iwona, Gregory, Richard C, Li, Cheryl, Wang, Shining, Stumpo, Kate, Kannan, Karuppiah, Miao, Harry, Levis, Mark
Published in Haematologica (Roma) (01.03.2023)
Published in Haematologica (Roma) (01.03.2023)
Get full text
Journal Article
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
Karantanos, Theodoros, Teodorescu, Patric, Arvanitis, Marios, Perkins, Brandy, Jain, Tania, DeZern, Amy E, Dalton, W Brian, Christodoulou, Ilias, Paun, Bogdan C, Varadhan, Ravi, Esteb, Christopher, Rajkhowa, Trivikram, Bonifant, Challice, Gondek, Lukasz P, Levis, Mark J, Yegnasubramanian, Srinivasan, Ghiaur, Gabriel, Jones, Richard J
Published in Haematologica (Roma) (01.07.2023)
Published in Haematologica (Roma) (01.07.2023)
Get full text
Journal Article
A potential therapeutic target for FLT3-ITD AML: PIM1 kinase
Fathi, Amir T, Arowojolu, Omotayo, Swinnen, Ian, Sato, Takashi, Rajkhowa, Trivikram, Small, Donald, Marmsater, Fredrik, Robinson, John E, Gross, Stefan David, Martinson, Matthew, Allen, Shelley, Kallan, Nicholas C, Levis, Mark
Published in Leukemia research (01.02.2012)
Published in Leukemia research (01.02.2012)
Get full text
Journal Article
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia
Karantanos, Theodoros, Teodorescu, Patric, Perkins, Brandy, Christodoulou, Ilias, Esteb, Christopher, Varadhan, Ravi, Helmenstine, Eric, Rajkhowa, Trivikram, Paun, Bogdan C, Bonifant, Challice, Dalton, W Brian, Gondek, Lukasz P, Moliterno, Alison R, Levis, Mark J, Ghiaur, Gabriel, Jones, Richard J
Published in Science advances (18.02.2022)
Published in Science advances (18.02.2022)
Get full text
Journal Article
Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia
Chen, Yi-Bin, Li, Shuli, Lane, Andrew A, Connolly, Christine, Del Rio, Candice, Valles, Betsy, Curtis, Morgan, Ballen, Karen, Cutler, Corey, Dey, Bimalangshu R, El-Jawahri, Areej, Fathi, Amir T, Ho, Vincent T, Joyce, Amy, McAfee, Steven, Rudek, Michelle, Rajkhowa, Trivikram, Verselis, Sigitas, Antin, Joseph H, Spitzer, Thomas R, Levis, Mark, Soiffer, Robert
Published in Biology of blood and marrow transplantation (01.12.2014)
Published in Biology of blood and marrow transplantation (01.12.2014)
Get full text
Journal Article
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants
Galanis, Allison, Ma, Hayley, Rajkhowa, Trivikram, Ramachandran, Abhijit, Small, Donald, Cortes, Jorge, Levis, Mark
Published in Blood (02.01.2014)
Published in Blood (02.01.2014)
Get full text
Journal Article
Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor
Lee, Lauren Y., Hernandez, Daniela, Rajkhowa, Trivikram, Smith, Samuel C., Raman, Jayant Ranganathan, Nguyen, Bao, Small, Donald, Levis, Mark
Published in Blood (12.01.2017)
Published in Blood (12.01.2017)
Get full text
Journal Article
Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
Strati, Paolo, Kantarjian, Hagop, Ravandi, Farhad, Nazha, Aziz, Borthakur, Gautam, Daver, Naval, Kadia, Tapan, Estrov, Zeev, Garcia‐Manero, Guillermo, Konopleva, Marina, Rajkhowa, Trivikram, Durand, Menda, Andreeff, Michael, Levis, Mark, Cortes, Jorge
Published in American journal of hematology (01.04.2015)
Published in American journal of hematology (01.04.2015)
Get full text
Journal Article
CCRL2 Promotes Cytokine-Regulated Growth of Erythroleukemia Cells
Karantanos, Theodoros, Esteb, Christopher, Teodorescu, Patric, Perkins, Brandy, Christodoulou, Ilias, Vorri, Stamatia, Rajkhowa, Trivikram, Dalton, William Brian, Ghiaur, Gabriel, Jones, Richard J.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
Chang, E, Ganguly, S, Rajkhowa, T, Gocke, C D, Levis, M, Konig, H
Published in Leukemia (01.05.2016)
Published in Leukemia (01.05.2016)
Get full text
Journal Article
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia
Levis, Mark, Perl, Alexander, Schiller, Gary, Fathi, Amir T., Roboz, Gail, Wang, Eunice S., Altman, Jessica, Rajkhowa, Trivikram, Ando, Makoto, Suzuki, Takeaki, Subach, Ruth Ann, Maier, Gary, Madden, Timothy, Johansen, Mary, Cheung, Kin, Kurman, Michael, Smith, Catherine
Published in Blood advances (28.05.2024)
Published in Blood advances (28.05.2024)
Get full text
Journal Article
Abstract 3660: Crenolanib: A next generation FLT3 inhibitor
Galanis, Allison, Rajkhowa, Trivikram, Muralidhara, Chaitanya, Ramachandran, Abhijit, Levis, Mark
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Regulation of renal proximal tubule Na-K-ATPase by prostaglandins
Herman, Maryann B, Rajkhowa, Trivikram, Cutuli, Facundo, Springate, James E, Taub, Mary
Published in American Journal of Physiology - Renal Physiology (01.05.2010)
Published in American Journal of Physiology - Renal Physiology (01.05.2010)
Get full text
Journal Article
Crenolanib Is A Highly Potent, Selective, FLT3 TKI with Activity Against D835 Mutations
Galanis, Allison, Rajkhowa, Trivikram, Muralidhara, Chaitanya, Ramachandran, Abhijit, Levis, Mark J.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
FLT3 Mutant to Wild Type Allelic Ratio and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML
Levis, Mark, Sato, Takashi, Murphy, Kathleen, Rajkhowa, Trivikram, Pratz, Keith
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Evidence for post-transcriptional regulation of Na,K-ATPase by prostaglandin E1
Borsick, Maryanne, Rajkhowa, Trivikram, Taub, Mary
Published in Biochemical and biophysical research communications (30.06.2006)
Published in Biochemical and biophysical research communications (30.06.2006)
Get full text
Journal Article